Hepatitis B/C and HIV in sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis

International Journal of Infectious Diseases

Volumn 14, Issue 12, 2010, Pages

  Barth, Roos E ^a   Huijgen, Quirine ^a   Taljaard, Jantjie ^b   Hoepelman, Andy I M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Africa; Hepatitis B; Hepatitis C; HIV; Meta analysis

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS C ANTIGEN;

AFRICA; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; MIXED INFECTION; PREVALENCE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

AFRICA SOUTH OF THE SAHARA; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; PREVALENCE;

EID: 78649704479     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.06.013     Document Type: Review

References (81)

1. Marcellin P. Hepatitis B and hepatitis C in 2009. Liver Int 2009, 29(Suppl 1):1-8.
2. Rockstroh J.K., Mocroft A., Soriano V., Tural C., Losso M.H., Horban A., et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005, 192:992-1002.
3. Thio C.L. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009, 49(5 Suppl):S138-S145.
4. Burnett R.J., Francois G., Kew M.C., Leroux-Roels G., Meheus A., Hoosen A.A., et al. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int 2005, 25:201-213.
5. Chen T.Y., Ding E.L., Seage Iii G.R., Kim A.Y. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 2009, 49:1605-1615.
6. Graham C.S., Baden L.R., Yu E., Mrus J.M., Carnie J., Heeren T., et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001, 33:562-569.
7. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
8. Higgins J.P. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 2008, 37:1158-1160.
9. Bax L., Yu L.M., Ikeda N., Tsuruta H., Moons K.G. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006, 6:50.
10. Wester C.W., Bussmann H., Moyo S., Avalos A., Gaolathe T., Ndwapi N., et al. Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana. Clin Infect Dis 2006, 43:1612-1615.
11. Ilboudo D., Karou D., Nadembega W.M., Savadogo A., Djeneba O., Pignatelli S., et al. Prevalence of human herpes virus-8 and hepatitis B virus among HIV seropositive pregnant women enrolled in the Mother-to-Child HIV Transmission Prevention Program at Saint Camille Medical Centre in Burkina Faso. Pak J Biol Sci 2007, 10:2831-2837.
12. Simpore J., Savadogo A., Ilboudo D., Nadambega M.C., Esposito M., Yara J., et al. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol 2006, 78:730-733.
13. Collenberg E., Ouedraogo T., Ganame J., Fickenscher H., Kynast-Wolf G., Becher H., et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: a comparative analysis. J Med Virol 2006, 78:683-692.
14. Simpore J., Ilboudo D., Samandoulougou A., Guardo P., Castronovo P., Musumeci S. HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina Faso). J Med Virol 2005, 75:209-212.
15. Simpore J., Granato M., Santarelli R., Nsme R.A., Coluzzi M., Pietra V., et al. Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso. J Clin Virol 2004, 31:78-80.
16. Laurent C., Bourgeois A., Mpoudi M., Butel C., Mpoudi-Ngole E., Delaporte E. HIV and hepatitis C virus coinfection, Cameroon. Emerg Infect Dis 2007, 13:514-516.
17. Mbanya D.N., Takam D., Ndumbe P.M. Serological findings amongst first-time blood donors in Yaounde, Cameroon: is safe donation a reality or a myth?. Transfus Med 2003, 13:267-273.
18. Pawlotsky J.M., Belec L., Gresenguet G., Deforges L., Bouvier M., Duval J., et al. High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol 1995, 46:269-272.
19. Laurent C., Henzel D., Mulanga-Kabeya C., Maertens G., Larouze B., Delaporte E. Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo. Int J Epidemiol 2001, 30:872-877.
20. Rouet F., Chaix M.L., Inwoley A., Msellati P., Viho I., Combe P., et al. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 study. J Med Virol 2004, 74:34-40.
21. Combe P., La Ruche G., Bonard D., Ouassa T., Faye-Ketté H., Sylla-Koko F., et al. Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Cote d'Ivoire, West Africa. Trans R Soc Trop Med Hyg 2001, 95:493-496.
22. Ouattara S.A., Meite M., Aron Y., Akran V., Gody M., Manlan L.K., et al. Increase of the prevalence of hepatitis B virus surface antigen related to immunodeficiency inherent in acquired immune deficiency syndrome (AIDS). J Acquir Immune Defic Syndr 1990, 3:282-286.
23. Shimelis T., Torben W., Medhin G., Tebeje M., Andualm A., Demessie F., et al. Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia. Sex Transm Infect 2008, 84:37-41.
24. Tiruneh M. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia. Ethiop Med J 2008, 46:359-366.
25. Diro E., Alemu S., G/Yohannes A. Blood safety and prevalence of transfusion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital. Ethiop Med J 2008, 46:7-13.
26. Ayele W., Nokes D.J., Abebe A., Messele T., Dejene A., Enquselassie F., et al. Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia. J Med Virol 2002, 68:12-17.
27. Rahlenbeck S.I., Yohannes G., Molla K., Reifen R., Assefa A. Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors. Int J STD AIDS 1997, 8:261-264.
28. Brandful J.A., Apeagyei F.A., Ampofo W.K., Adu-Sarkodie Y., Ansah J.E., Nuvor V., et al. Relationship between immunoclinical status and prevalence of viral sexually transmitted diseases among human immunodeficiency virus-1 seropositive patients in Ghana. Viral Immunol 1999, 12:131-137.
29. Harania R.S., Karuru J., Nelson M., Stebbing J. HIV, hepatitis B and hepatitis C coinfection in Kenya. AIDS 2008, 22:1221-1222.
30. Abdalla F., Mwanda O.W., Rana F. Comparing walk-in and call-responsive donors in a national and a private hospital in Nairobi. East Afr Med J 2005, 82:531-535.
31. Ogutu E.O., Amayo E.O., Okoth F., Lule G.N. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS). East Afr Med J 1990, 67:355-358.
32. Nyirenda M., Beadsworth M.B., Stephany P., Hart C.A., Hart I.J., Munthali C., et al. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. J Infect 2008, 57:72-77.
33. Sutcliffe S., Taha T.E., Kumwenda N.I., Taylor E., Liomba G.N. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi. J Acquir Immune Defic Syndr 2002, 31:90-97.
34. Ahmed S.D., Cuevas L.E., Brabin B.J., Kazembe P., Broadhead R., Verhoeff F.H., et al. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect 1998, 37:248-251.
35. Tounkara A., Sarro Y.S., Kristensen S., Dao S., Diallo H., Diarra B., et al. Seroprevalence of HIV/HBV coinfection in Malian blood donors. J Int Assoc Physicians AIDS Care (Chic Ill) 2009, 8:47-51.
36. Rodrigues Mda C., Viotti J.B., Braga R.F., Lourenco L.F., Antunes C.M., Lambertucci J.R. HIV/HCV coinfection in infectious disease units in Mozambique and Brazil: a comparative study. Rev Soc Bras Med Trop 2008, 41:518.
37. Cunha L., Plouzeau C., Ingrand P., Gudo J.P., Ingrand I., Mondlane J., et al. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol 2007, 79:1832-1840.
38. Adewole O.O., Anteyi E., Ajuwon Z., Wada I., Elegba F., Ahmed P., et al. Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries 2009, 3:369-375.
39. Otegbayo J.A., Taiwo B.O., Akingbola T.S., Odaibo G.N., Adedapo K.S., Penugonda S., et al. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol 2008, 7:152-156.
40. Ladep N.G., Agbaji O., Agaba P., Badung P., Imade G., Sankalé J., et al. Does immunological status affect the prevalence of hepatitis C virus infection among HIV/AIDS patients?. Niger J Med 2007, 16:231-234.
41. Forbi J.C., Gabadi S., Alabi R., Iperepolu H.O., Pam C.R., Entonu P.E., et al. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. Mem Inst Oswaldo Cruz 2007, 102:535-537.
42. Iwalokun B.A., Hodonu S.O., Olaleye B.M., Olabisi O.A. Seroprevalence and biochemical features of hepatitis B surface antigenemia in patients with HIV-1 infection in Lagos, Nigeria. Afr J Med Sci 2006, 35:337-343.
43. Nwokedi E.E., Emokpae M.A., Dutse A.I. Human immunodeficiency virus and hepatitis B virus co-infection among patients in Kano Nigeria. Niger J Med 2006, 15:227-229.
44. Uneke C.J., Ogbu O., Inyama P.U., Anyanwu G.I., Njoku M.O., Idoko J.H. Prevalence of hepatitis B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz 2005, 100:13-16.
45. Agwale S.M., Tanimoto L., Womack C., Odama L., Leung K., Duey D., et al. Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. J Clin Virol 2004, 31(Suppl 1):S3-6.
46. Oronsaye F.E., Oronsaye J.I. Prevalence of HIV-positives and hepatitis B surface antigen-positives among donors in the University of Benin Teaching Hospital, Nigeria. Trop Doct 2004, 34:159-160.
47. Ejele O.A., Nwauche C.A., Erhabor O. The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta Nigeria. Niger J Med 2004, 13:175-179.
48. Otuonye N.M., Olukoya D.K., Odunukwe N.N., Idigbe E.O., Udeaja M.N., Bamidele M., et al. HIV association with conventional STDS (sexual transmitted diseases) in Lagos State, Nigeria. West Afr J Med 2002, 21:153-156.
49. Diop-Ndiaye H., Toure-Kane C., Etard J.F., Lô G., Diaw P., Ngom-Gueye N.F., et al. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). J Med Virol 2008, 80:1332-1336.
50. Lukhwareni A., Burnett R.J., Selabe S.G., Mzileni M.O., Mphahlele M.J. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a tertiary hospital. J Med Virol 2009, 81:406-412.
51. Firnhaber C., Viana R., Reyneke A., Schultze D., Malope B., Maskew M., et al. Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis 2009, 13:488-492.
52. Hoffmann C.J., Charalambous S., Martin D.J., Innes C., Churchyard G.J., Chaisson R.E., et al. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis 2008, 47:1479-1485.
53. Parboosing R., Paruk I., Lalloo U.G. Hepatitis C virus seropositivity in a South African cohort of HIV co-infected, ARV naive patients is associated with renal insufficiency and increased mortality. J Med Virol 2008, 80:1530-1536.
54. Burnett R.J., Ngobeni J.M., Francois G., Hoosen A.A., Leroux-Roels G., Meheus A., et al. Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women. Int J STD AIDS 2007, 18:152-156.
55. Mphahlele M.J., Lukhwareni A., Burnett R.J., Moropeng L.M., Ngobeni J.M. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 2006, 35:14-20.
56. Lodenyo H., Schoub B., Ally R., Kairu S., Segal I. Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg. East Afr Med J 2000, 77:13-15.
57. Klugman K.P., Patel J., Sischy A., McIntyre J.A. Serological markers of sexually transmitted diseases associated with HIV-1 infection in pregnant black women. S Afr Med J 1991, 80:243-244.
58. Nagu T.J., Bakari M., Matee M. Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2008, 8:416.
59. Msuya S.E., Mbizvo E.M., Hussain A., Sam N.E., Stray-Pedersen B. Seroprevalence of hepatitis B and C viruses among women of childbearing age in Moshi Urban, Tanzania. East Afr Med J 2006, 83:91-94.
60. Matee M.I., Magesa P.M., Lyamuya E.F. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2006, 6:21.
61. Tess B.H., Levin A., Brubaker G., Shao J., Drummond J.E., Alter H.J., et al. Seroprevalence of hepatitis C virus in the general population of northwest Tanzania. Am J Trop Med Hyg 2000, 62:138-141.
62. Menendez C., Sanchez-Tapias J.M., Kahigwa E., Mshinda H., Costa J., Vidal J., et al. Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania. J Med Virol 1999, 58:215-220.
63. Bwogi J., Braka F., Makumbi I., Mishra V., Bakamutumaho B., Nanyunja M., et al. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci 2009, 9:98-108.
64. Pirillo M.F., Bassani L., Germinario E.A., Mancini M.G., Vyankandondera J., Okong P., et al. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda. J Med Virol 2007, 79:1797-1801.
65. Nakwagala F.N., Kagimu M.M. Hepatitis B virus and HIV infections among patients in Mulago hospital. East Afr Med J 2002, 79:68-72.
66. de Lalla F., Rizzardini G., Rinaldi E., Santoro D., Zeli P.L., Verga G. HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas. Trans R Soc Trop Med Hyg 1990, 84:144-147.
67. Kashala O., Mubikayi L., Kayembe K., Mukeba P., Essex M. Hepatitis B virus activation among central Africans infected with human immunodeficiency virus (HIV) type 1: pre-s2 antigen is predominantly expressed in HIV infection. J Infect Dis 1994, 169:628-632.
68. Oshitani H., Kasolo F.C., Mpabalwani M., Mizuta K., Luo N.P., Suzuki H., et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. Trans R Soc Trop Med Hyg 1996, 90:235-236.
69. Kallestrup P., Zinyama R., Gomo E., Dickmeiss E., Platz P., Gerstoft J., et al. Low prevalence of hepatitis C virus antibodies in HIV-endemic area of Zimbabwe support sexual transmission as the major route of HIV transmission in Africa. AIDS 2003, 17:1400-1402.
70. Cooper C.L., Mills E., Wabwire B.O., Ford N., Olupot-Olupot P. Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa. Int J Infect Dis 2009, 13:302-306.
71. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97-107.
72. Modi A.A., Feld J.J. Viral hepatitis and HIV in Africa. AIDS Rev 2007, 9:25-39.
73. World Health Organization. AIDS epidemic update 2007. Geneva: WHO; 2007. Available at: (accessed September 14th 2010). http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive /2007/.
74. Cassino L., Laufer N., Salomon H., Campos R., Quarleri J. Hepatitis B precore/core promoter mutations in isolates from HBV-monoinfected and HBV-HIV coinfected patients: a 3-yr prospective study. J Clin Virol 2009, 46:354-359.
75. Revill P.A., Littlejohn M., Ayres A., Yuen L., Colledge D., Bartholomeusz A., et al. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals. AIDS 2007, 21:1701-1710.
76. Nikolopoulos G.K., Paraskevis D., Hatzitheodorou E., Moschidis Z., Sypsa V., Zavitsanos X., et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis 2009, 48:1763-1771.
77. Liaw Y.F., Leung N.W., Chang T.T., Guan R., Tai D.I., Ng K.Y., et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology 2000, 119:172-180.
78. Lok A.S., Hussain M., Cursano C., Margotti M., Gramenzi A., Grazi G.L., et al. Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy. Hepatology 2000, 32:1145-1153.
79. Marcellin P., Heathcote E.J., Buti M., Gane E., de Man R.A., Krastev Z., et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008, 359:2442-2455.
80. Lim S.G., Wai C.T., Rajnakova A., Kajiji T., Guan R. Fatal hepatitis B reactivation following discontinuation of nucleoside analogues for chronic hepatitis B. Gut 2002, 51:597-599.
81. Cohen Stuart J.W., Velema M., Schuurman R., Boucher C.A., Hoepelman A.I. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol 2009, 81:441-445.